These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 8628167)

  • 1. Managing HIV. Part 4: Primary therapy. 4.3 The laboratory in managing HIV infection.
    Dwyer DE; Adelstein S; Cunningham AL; Merigan TC
    Med J Aust; 1996 Mar; 164(5):301-3. PubMed ID: 8628167
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A decade of research on the natural history of HIV infection: Part 1. Markers.
    Strathdee SA; O'Shaughnessy MV; Montaner JS; Schechter MT
    Clin Invest Med; 1996 Apr; 19(2):111-20. PubMed ID: 8697670
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Laboratory markers associated with progression of HIV infection.
    Kiepiela P; Smith AN; Rosenberg E
    Best Pract Res Clin Obstet Gynaecol; 2005 Apr; 19(2):243-54. PubMed ID: 15778113
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The prognostic value of cellular and serologic markers in infection with human immunodeficiency virus type 1.
    Dis Markers; 1990; 8(3):164-5. PubMed ID: 2125538
    [No Abstract]   [Full Text] [Related]  

  • 5. Laboratory methods for diagnosing and monitoring HIV infection.
    Grady C; Vogel S
    J Assoc Nurses AIDS Care; 1993; 4(2):11-21; quiz 22-3. PubMed ID: 8369497
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic value of serum beta 2-microglobulin in HIV infection.
    Krämer A; Goedert JJ; Wachter H; Fuchs D
    Lancet; 1992 Aug; 340(8815):371. PubMed ID: 1379663
    [No Abstract]   [Full Text] [Related]  

  • 7. Dynamics of HIV-1 viral load in pregnancy.
    Lillo FB; Bucceri AM; Bettini P; Farma E; Boeri E; Mastrorilli E; Rossi G; Vignali M; Varnier OE
    AIDS; 1997 Sep; 11(11):1397-8. PubMed ID: 9302452
    [No Abstract]   [Full Text] [Related]  

  • 8. Neopterin levels during the early phase of human immunodeficiency virus, hepatitis C virus, or hepatitis B virus infection.
    Nübling CM; Chudy M; Volkers P; Löwer J
    Transfusion; 2006 Nov; 46(11):1886-91. PubMed ID: 17076842
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rapid plasma virus and CD4+ T-cell turnover in HIV-1 infection: evidence for an only transient interruption by treatment.
    Stellbrink HJ; Zöller B; Fenner T; Lichtenberg G; van Lunzen J; Albrecht H; Thiele HG; Greten H
    AIDS; 1996 Jul; 10(8):849-57. PubMed ID: 8828742
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Residual viraemia in HIV-1-infected patients with plasma viral load Ostrowski SR; Katzenstein TL; Pedersen BK; Gerstoft J; Ullum H
    Scand J Immunol; 2008 Dec; 68(6):652-60. PubMed ID: 19055701
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Measurement of HIV-1 p24 antigen by signal-amplification-boosted ELISA of heat-denatured plasma is a simple and inexpensive alternative to tests for viral RNA.
    Schüpbach J
    AIDS Rev; 2002; 4(2):83-92. PubMed ID: 12152521
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship of neurological manifestations, CD4+ lymphocyte count and plasma viral load in HIV infected patients.
    Gochitashvili N; Tsertsvadze T; Gatserelia L; Abashidze L; Sharvadze L
    Georgian Med News; 2005 Apr; (121):51-5. PubMed ID: 15908725
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beta-2-microglobulin, neopterin and monocyte Fc gamma receptors in opportunistic infections of HIV-positive patients.
    Dunne J; Feighery C; Whelan A
    Br J Biomed Sci; 1996 Dec; 53(4):263-9. PubMed ID: 9069103
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lowering the detection limits of HIV-1 viral load using real-time immuno-PCR for HIV-1 p24 antigen.
    Barletta JM; Edelman DC; Constantine NT
    Am J Clin Pathol; 2004 Jul; 122(1):20-7. PubMed ID: 15272526
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heat-mediated immune complex dissociation and enzyme-linked immunosorbent assay signal amplification render p24 antigen detection in plasma as sensitive as HIV-1 RNA detection by polymerase chain reaction.
    Schüpbach J; Flepp M; Pontelli D; Tomasik Z; Lüthy R; Böni J
    AIDS; 1996 Sep; 10(10):1085-90. PubMed ID: 8874624
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early markers of HIV infection and subclinical disease progression.
    Dolan MJ; Lucey DR; Hendrix CW; Melcher GP; Spencer GA; Boswell RN
    Vaccine; 1993; 11(5):548-51. PubMed ID: 8098175
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A randomized controlled trial of a protease inhibitor (saquinavir) in combination with zidovudine in previously untreated patients with advanced HIV infection.
    Vella S; Lazzarin A; Carosi G; Sinicco A; Armignacco O; Angarano G; Andreoni M; Tambussi G; Chiodera A; Floridia M; Scaccabarozzi S; Facey K; Duncan I; Boudes P; Bragman K
    Antivir Ther; 1996 Aug; 1(3):129-40. PubMed ID: 11322246
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Serum neopterin and beta2-microglobulin concentration as "prognostic markers" of AIDS].
    Halota W; Jaruga B; Pawłowska M
    Pol Merkur Lekarski; 2002 Aug; 13(74):126-8. PubMed ID: 12420343
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effector HIV-specific cytotoxic T-lymphocyte activity in long-term nonprogressors: associations with viral replication and progression.
    Keoshkerian E; Ashton LJ; Smith DG; Ziegler JB; Kaldor JM; Cooper DA; Stewart GJ; Ffrench RA
    J Med Virol; 2003 Dec; 71(4):483-91. PubMed ID: 14556259
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationships among the detection of p24 antigen, human immunodeficiency virus (HIV) RNA level, CD4 cell count, and disease progression in HIV-infected individuals with hemophilia.
    Sabin CA; Lepri AC; Devereux H; Phillips AN; Loveday C; Lee CA
    J Infect Dis; 2001 Aug; 184(4):511-4. PubMed ID: 11471111
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.